Louis Manzo, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 100,000 shares at $2.40 ($240K) on 2016-03-16, disclosed to the SEC on 2016-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |